학술논문
Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients.
Document Type
journal article
Author
Source
Critical Care Medicine; 2001 Mar, Vol. 29 Issue 3, p503-510, 8p
Subject
Language
ISSN
00903493